JP2016514142A - 薬物及び栄養補助剤のバイオアベイラビリティを高める方法及び生成物 - Google Patents

薬物及び栄養補助剤のバイオアベイラビリティを高める方法及び生成物 Download PDF

Info

Publication number
JP2016514142A
JP2016514142A JP2016501583A JP2016501583A JP2016514142A JP 2016514142 A JP2016514142 A JP 2016514142A JP 2016501583 A JP2016501583 A JP 2016501583A JP 2016501583 A JP2016501583 A JP 2016501583A JP 2016514142 A JP2016514142 A JP 2016514142A
Authority
JP
Japan
Prior art keywords
drug
tetrandrine
family member
nutritional supplement
tetrandrine family
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016501583A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016514142A5 (OSRAM
Inventor
バーネット、ダリル・エル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CBA Pharma Inc
Original Assignee
CBA Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CBA Pharma Inc filed Critical CBA Pharma Inc
Publication of JP2016514142A publication Critical patent/JP2016514142A/ja
Publication of JP2016514142A5 publication Critical patent/JP2016514142A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
JP2016501583A 2013-03-15 2014-03-12 薬物及び栄養補助剤のバイオアベイラビリティを高める方法及び生成物 Pending JP2016514142A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361792700P 2013-03-15 2013-03-15
US61/792,700 2013-03-15
PCT/US2014/024592 WO2014150935A1 (en) 2013-03-15 2014-03-12 Method and products for enhancing drug and dietary supplement bioavailability

Publications (2)

Publication Number Publication Date
JP2016514142A true JP2016514142A (ja) 2016-05-19
JP2016514142A5 JP2016514142A5 (OSRAM) 2017-05-18

Family

ID=51529972

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016501583A Pending JP2016514142A (ja) 2013-03-15 2014-03-12 薬物及び栄養補助剤のバイオアベイラビリティを高める方法及び生成物

Country Status (7)

Country Link
US (1) US9345257B2 (OSRAM)
EP (1) EP2986122A4 (OSRAM)
JP (1) JP2016514142A (OSRAM)
KR (1) KR20150143504A (OSRAM)
CN (1) CN105357966A (OSRAM)
MX (1) MX2015013158A (OSRAM)
WO (1) WO2014150935A1 (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2986122A4 (en) 2013-03-15 2017-01-18 CBA Pharma Inc. Method and products for enhancing drug and dietary supplement bioavailability
JP2016514143A (ja) * 2013-03-15 2016-05-19 シービーエー・ファーマ・インコーポレイテッドCba Pharma, Inc. 薬物及び栄養補助剤の細胞取り込みを高める方法及び生成物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911454B1 (en) * 1989-09-28 2005-06-28 Cancer Biologics Of America, Inc. Method for potentiating primary drugs in treating multidrug resistant disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6086915A (en) 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
US7799802B2 (en) * 2004-08-03 2010-09-21 Institstute of Oriental Medical Science Inc. Method and health food for preventing and/or alleviating psychiatric disorder, and/or for effectuating sedation
EP2986122A4 (en) 2013-03-15 2017-01-18 CBA Pharma Inc. Method and products for enhancing drug and dietary supplement bioavailability
JP2016514143A (ja) * 2013-03-15 2016-05-19 シービーエー・ファーマ・インコーポレイテッドCba Pharma, Inc. 薬物及び栄養補助剤の細胞取り込みを高める方法及び生成物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911454B1 (en) * 1989-09-28 2005-06-28 Cancer Biologics Of America, Inc. Method for potentiating primary drugs in treating multidrug resistant disease

Also Published As

Publication number Publication date
EP2986122A4 (en) 2017-01-18
US20140275140A1 (en) 2014-09-18
MX2015013158A (es) 2016-04-15
CN105357966A (zh) 2016-02-24
WO2014150935A1 (en) 2014-09-25
EP2986122A1 (en) 2016-02-24
US9345257B2 (en) 2016-05-24
KR20150143504A (ko) 2015-12-23

Similar Documents

Publication Publication Date Title
JP2021167343A (ja) パルボシクリブの固形剤形
CA3149460C (en) Drug composition containing abiraterone acetate, and preparation method therefor and application thereof
RU2668882C2 (ru) Жидкая фармацевтическая композиция
TWI654981B (zh) 包含度他雄胺和丙二醇單月桂酸酯的醫藥組成物及其製備方法
JP2013509395A5 (OSRAM)
CN104306363B (zh) 芪类衍生物及其药学可接受的盐在制备治疗高尿酸血症药物中的应用
JP2008508326A (ja) 腸内投与のための担体
JP2016512818A (ja) テトランドリンファミリーの医薬製剤及び方法
JP2016514142A (ja) 薬物及び栄養補助剤のバイオアベイラビリティを高める方法及び生成物
US20140073670A1 (en) Pharmaceutical composition comprising fexofenadine
KR101618373B1 (ko) 경구 투여가 가능한 항피로에 효과를 나타내는 새로운 복합비타민 제제
CN104936585B (zh) 包括苯肾上腺素和扑热息痛的组合药剂
KR20140103281A (ko) 게실증의 치료를 위한 방법 및 조성물
US20140275138A1 (en) Method and products for treating diabetes
JP2016514143A (ja) 薬物及び栄養補助剤の細胞取り込みを高める方法及び生成物
JP6197515B2 (ja) 医薬組成物
CN102552210B (zh) 一种恩替卡韦胶囊组合物及其制备方法
JP2016514142A5 (OSRAM)
JP2017515858A5 (OSRAM)
Pandey et al. Formulation development and evaluation of fast dissolving acelofenac tablets
JPS6360926A (ja) 感冒薬
RU2446803C1 (ru) Лекарственное средство в виде капсул, обладающее противовирусным и интерфероногенным действием
AU2012260992A1 (en) Pharmaceutical composition comprising fexofenadine
OA19944A (en) Pharmaceutical composition comprising fexofenadine.
JPH07179346A (ja) 胃腸治療剤

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170310

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170328

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171114

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180214

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180416

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180514

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20180626